GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Technologies Inc (FRA:J7J) » Definitions » YoY EBITDA Growth

Monogram Technologies (FRA:J7J) YoY EBITDA Growth : 30.63% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Monogram Technologies YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Monogram Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 30.63%.

Monogram Technologies's EBITDA per Share for the three months ended in Dec. 2024 was €-0.08.


Monogram Technologies YoY EBITDA Growth Historical Data

The historical data trend for Monogram Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Technologies YoY EBITDA Growth Chart

Monogram Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -393.75 -20.25 -6.67 -126.97 36.81

Monogram Technologies Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.59 11.30 61.48 -20.51 30.63

Monogram Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Monogram Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.436--0.69)/ | -0.69 |
=36.81 %

Monogram Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.077--0.111)/ | -0.111 |
=30.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monogram Technologies YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Monogram Technologies's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Monogram Technologies Business Description

Traded in Other Exchanges
Address
3913 Todd Lane, Suite 307, Austin, TX, USA, 78744
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Monogram Technologies Headlines

No Headlines